In a stable long‑term care resident with recurrent urinary tract infections, diabetes, chronic mixed urinary incontinence, and a planned repeat bladder botulinum toxin injection, who now has new lower urinary symptoms and a urine culture growing >100,000 CFU/mL gram‑negative rod (organism and susceptibilities pending) with normal renal function (eGFR > 60 mL/min), should I start empiric nitrofurantoin (instead of cephalexin) while awaiting susceptibility results and send the culture to the ordering provider to coordinate antibiotic management and the timing of the Botox procedure?

Empiric Antibiotic Selection for Symptomatic UTI in Long-Term Care Resident

Yes, start empiric nitrofurantoin (100 mg BID for 5-7 days) rather than cephalexin for this stable patient with new lower urinary symptoms, normal renal function, and pending culture results, and coordinate immediately with the urologist regarding culture results and Botox timing. 1

Rationale for Nitrofurantoin Over Cephalexin

Why Nitrofurantoin is Superior Here

Nitrofurantoin is the first-line agent for uncomplicated lower UTI in women according to the most recent 2025 AUA/CUA/SUFU guidelines 1. The key advantages in your patient include:

• Narrow antimicrobial spectrum targeting E. coli and common uropathogens without collateral damage to the microbiome 1
• Low, stable resistance rates maintained over 50 years 1
• 88-93% cure rate for localized symptomatic UTI 1
• Safe in diabetes and recurrent UTI patients - this patient's exact profile 1, 2
• Effective with eGFR >60 mL/min - your patient has eGFR 102, well above the threshold 1

Why NOT Cephalexin

Cephalexin is explicitly not recommended as first-line therapy for uncomplicated UTI 1. The 2024 EAU guidelines reserve cephalosporins for complicated UTI with systemic symptoms, typically requiring second-generation agents plus aminoglycosides 3. Cephalosporins cause greater collateral damage to the microbiome and are associated with increased C. difficile risk 1. In your long-term care resident with recurrent UTIs, preserving the microbiome is critical.

Addressing the Complicated vs. Uncomplicated Question

This Patient Has Features of BOTH

Your patient technically has complicated UTI risk factors 3:

• Diabetes mellitus
• Recurrent UTIs
• Long-term care residence (healthcare-associated)
• Chronic urinary incontinence
• Planned instrumentation (Botox)

However, if she is hemodynamically stable with new lower urinary symptoms only (no fever, flank pain, altered mental status, or systemic symptoms), treat this as localized symptomatic UTI with oral first-line therapy 1, 3.

The Critical Decision Point

If stable with lower tract symptoms only:

• Nitrofurantoin 100 mg BID for 5-7 days 1
• Duration of 7 days is reasonable given diabetes and recurrent UTI history 3

If ANY systemic symptoms develop (fever, rigors, flank pain, altered mental status):

• This becomes complicated UTI requiring broader coverage
• Consider IV third-generation cephalosporin or fluoroquinolone (if local resistance <10%) 3
• Hospitalization may be needed

Coordination with Urology for Botox Procedure

Send Culture Results Immediately - This is Essential

Yes, absolutely send the full culture and susceptibility report to the urologist NOW for several critical reasons:

1. UTI increases post-Botox infection risk - Active UTI at time of bladder instrumentation significantly increases risk of symptomatic UTI and bacteremia 3, 4

2. Timing considerations - The urologist needs to know:

   • Whether to proceed with scheduled Botox
   • Whether to delay until UTI fully treated and cleared
   • Standard practice is to ensure sterile urine before elective bladder procedures 3

3. Antibiotic selection matters - If organism shows resistance to nitrofurantoin, you'll need to adjust therapy before the procedure 3

Recommended Coordination Steps

• Obtain full culture identification and susceptibilities urgently
• Contact urologist today with preliminary culture results (gram-negative rod, >100,000 CFU/mL)
• Discuss timing: Most urologists will want documented UTI clearance (negative culture or at minimum completion of appropriate antibiotic course) before proceeding with Botox 3
• Plan repeat urinalysis/culture after completing antibiotics if Botox is rescheduled

Important Caveats and Pitfalls

Renal Function Monitoring

While her current eGFR is 102, verify current creatinine as you mentioned. Nitrofurantoin requires eGFR ≥30 mL/min for safety (updated from previous ≥60 threshold) 5, 6. The 2015 Beers criteria update allows short-term use with eGFR ≥30 5.

Confirm True Symptomatic UTI

You noted discrepancy between current report of symptoms and prior documentation of no new urinary symptoms. This is critical - do not treat asymptomatic bacteriuria (ASB), even in diabetics with recurrent UTI history 1. Treatment of ASB:

• Increases risk of symptomatic recurrence (47% vs 13%, RR 3.17) 1
• Promotes antibiotic resistance 1
• Provides no clinical benefit 1

Document specifically: new dysuria, urgency, frequency, suprapubic pain - not just worsening baseline incontinence 3.

Diabetes Does NOT Change First-Line Therapy

Despite older teaching, diabetes alone does not mandate broader-spectrum antibiotics for uncomplicated lower UTI 1, 2. Nitrofurantoin remains appropriate and effective 2.

Post-Botox UTI Risk

Be aware that UTI incidence may increase after bladder Botox in OAB patients, though interestingly some data suggest decreased UTI rates in neurogenic patients 4, 7. This patient will need close monitoring post-procedure.

Adjusting Based on Culture Results

Once susceptibilities return:

• If susceptible to nitrofurantoin: Continue current therapy
• If resistant: Switch to susceptible agent, likely requiring 7-day course from switch date 3
• If ESBL-producing organism: Nitrofurantoin often remains effective for lower UTI despite ESBL 8
• Notify urologist immediately of any resistance patterns